These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9364984)

  • 1. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tissue plasminogen activator specificity using peptidyl fluorogenic substrates.
    Butenas S; Kalafatis M; Mann KG
    Biochemistry; 1997 Feb; 36(8):2123-31. PubMed ID: 9047311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorogenic substrates for activated protein C: substrate structure-efficiency correlation.
    Butenas S; Drungilaite V; Mann KG
    Anal Biochem; 1995 Mar; 225(2):231-41. PubMed ID: 7762785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New fluorogenic peptide substrates for plasmin.
    Kato H; Adachi N; Ohno Y; Iwanaga S; Takada K; Sakakibara S
    J Biochem; 1980 Jul; 88(1):183-90. PubMed ID: 6447693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes.
    Butenas S; Orfeo T; Lawson JH; Mann KG
    Biochemistry; 1992 Jun; 31(23):5399-411. PubMed ID: 1606166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysis.
    Bergstrom RC; Coombs GS; Ye S; Madison EL; Goldsmith EJ; Corey DR
    Biochemistry; 2003 May; 42(18):5395-402. PubMed ID: 12731881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
    Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L
    Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Maly DJ; Ellman JA; Diamond SL
    Proteomics; 2005 Apr; 5(5):1292-8. PubMed ID: 15742319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates.
    Meng Y; High K; Antonello J; Washabaugh MW; Zhao Q
    Anal Biochem; 2005 Oct; 345(2):227-36. PubMed ID: 16137635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
    Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.
    Claeson G
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):411-36. PubMed ID: 8075312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.